menu ☰
menu ˟

FDA approves romosozumab for osteoporosis

09 Apr 2019
The FDA on Tuesday approved the monoclonal antibody romosozumab to treat osteoporosis in postmenopausal women at high risk for fracture, according to a press release from the agency.The approval of romosozumab (Evenity, Amgen) is indicated for women ...

Click here to view the full article which appeared in Rheumatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.